These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11368382)

  • 41. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL.
    Nash RA; Storb R
    Curr Opin Immunol; 1996 Oct; 8(5):674-80. PubMed ID: 8902393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Merocyanine 540-mediated photosensitization of leukemia and solid tumor cells.
    Sieber F
    Prog Clin Biol Res; 1985; 172B():227-34. PubMed ID: 3887425
    [No Abstract]   [Full Text] [Related]  

  • 44. Blood or marrow?
    Bensinger WI; Deeg HJ
    Lancet; 2000 Apr; 355(9211):1199-200. PubMed ID: 10770296
    [No Abstract]   [Full Text] [Related]  

  • 45. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 46. [Allogeneic peripheral blood stem cell transplantation].
    Harada M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1877-85. PubMed ID: 8978790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
    Schmitz N; Beksac M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szerm J; Bradstock K; Buzyn A; Schlegelberger B; Matcham J; Gratwohl A
    Haematologica; 2005 May; 90(5):643-8. PubMed ID: 15921379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplantation.
    Curr Opin Oncol; 1997 Mar; 9(2):B41-7. PubMed ID: 9161802
    [No Abstract]   [Full Text] [Related]  

  • 49. [Allogeneic peripheral blood stem cell transplantation (allo PBSCT) compared with allogeneic bone marrow transplantation (allo BMT)].
    Tanaka J
    Rinsho Ketsueki; 2002 Jun; 43(6):442-6. PubMed ID: 12134697
    [No Abstract]   [Full Text] [Related]  

  • 50. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 51. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
    Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic blood stem cell transplantation.
    Ehninger G; Bornhäuser M
    Eur J Cancer; 2009 Sep; 45 Suppl 1():412-3. PubMed ID: 19775651
    [No Abstract]   [Full Text] [Related]  

  • 54. Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
    Dicke KA; Spitzer G; Peters L; Stevens EE; Hendriks W; McCredie tkb
    Transplant Proc; 1978 Mar; 10(1):217-21. PubMed ID: 416529
    [No Abstract]   [Full Text] [Related]  

  • 55. Graft-versus-host disease after marrow transplantation.
    Lancet; 1984 Mar; 1(8375):491-2. PubMed ID: 6142212
    [No Abstract]   [Full Text] [Related]  

  • 56. Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Byrne M; Savani BN; Mohty M; Nagler A
    Exp Hematol; 2016 Jul; 44(7):567-73. PubMed ID: 27106798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulocyte-mobilized bone marrow.
    Arcese W; De Angelis G; Cerretti R
    Curr Opin Hematol; 2012 Nov; 19(6):448-53. PubMed ID: 22954729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of GSTO2 (N142D), GSTT1, and GSTM1 Polymorphisms With Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Khosravi M; Izaddoust M; Saadat I; Karimi MH; Ramzi M
    Exp Clin Transplant; 2016 Aug; 14(4):436-40. PubMed ID: 26103006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?
    Koç H; Gürman G; Arslan O; Ozcan M; Dilek I; Akan H; Ilhan O; Konuk N; Beksaç M; Uysal A
    J Chemother; 1997 Oct; 9(5):371-6. PubMed ID: 9373793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.